- Home
- FGI vs PASG Comparison
FGI vs PASG Comparison
Compare FGI & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FGI | PASG |
|---|---|---|
| Founded | 1987 | 2017 |
| Country | United States | United States |
| Employees | N/A | 27 |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.0M | 14.8M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FGI | PASG |
|---|---|---|
| Price | $10.30 | $4.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 46.5K | 23.3K |
| Earning Date | 04-09-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.38 | N/A |
| Revenue Next Year | $6.06 | N/A |
| P/E Ratio | $58.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.14 | $3.29 |
| 52 Week High | $19.93 | $20.00 |
Technical Indicators
Market Signals| Indicator | FGI | PASG |
|---|---|---|
| Relative Strength Index (RSI) | 69.20 | 52.88 |
| Support Level | $5.25 | $4.27 |
| Resistance Level | $10.46 | $4.95 |
| Average True Range (ATR) | 0.60 | 0.25 |
| MACD | 0.13 | 0.04 |
| Stochastic Oscillator | 100.00 | 43.81 |
Price Performance
Historical ComparisonAbout FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, it generates the majority of its revenue from the United States, followed by Canada and Europe.
About PASG Passage Bio Inc.
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.